Skip to main content
. 2020 Jun 24;92(11):2631–2636. doi: 10.1002/jmv.26141

Table 3.

Comparison of time to achieve negative NAT and hospital stays of COVID‐19 patients in the two groups

Danoprevir LPV/r P value
Cases 5 28
Negative NAT, d
Median 7.0 12.0 .7903
Average 8.0 12.5 .0388*
Hospital stays, d
Median 9.0 17.0 .6802
Average 11.4 16.7 .0324*

Abbreviations: COVID‐19, coronavirus disease 2019; LPV/r, lopinavir/ritonavir; NAT, nucleic acid testing.

*

P < .05 was considered statistically significant.